Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 1/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | IRAK4 | Q9NWZ3 | 3/20 | 0.31 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7337066 | 0.92 | ITGB3 (0.53) | ITGB3ITGA2BRXFP1IRAK4GPR119 | |
| SCHEMBL7285055 | 0.92 | ITGB3 (0.53) | ITGB3ITGA2BRXFP1IRAK4GPR119 | |
| SCHEMBL7304269 | 0.91 | ITGB3 (0.54) | ITGB3ITGA2BIRAK4 | |
| SCHEMBL7283492 | 0.89 | ITGB3 (0.47) | ITGB3ITGA2BRXFP1IRAK4GPR119 | |
| SCHEMBL7277671 | 0.88 | ITGB3 (0.48) | ITGB3ITGA2BRXFP1IRAK4 | |
| SCHEMBL7278638 | 0.88 | ITGB3 (0.50) | ITGB3ITGA2BRXFP1IRAK4GPR119 | |
| SCHEMBL7311942 | 0.85 | ITGB3 (0.53) | ITGB3ITGA2BIRAK4 | |
| SCHEMBL7308125 | 0.84 | ITGB3 (0.52) | ITGB3ITGA2BIRAK4 | |
| SCHEMBL7316759 | 0.84 | ITGB3 (0.52) | ITGB3ITGA2BIRAK4 | |
| SCHEMBL7302804 | 0.84 | ITGB3 (0.54) | ITGB3ITGA2BIRAK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5455348-A | Anticoagulants | Thomae, Karl (DE) | 1995-10-03 | — | — | US | disclosed |
| EP-0528369-A2 | Cyclic imino derivatives, pharmaceutical compositions containing them and process for their preparation | Dr. Karl Thomae GmbH (DE) | 1993-02-24 | — | — | EP | disclosed |